ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026
ImmunityBioImmunityBio(US:IBRX) Businesswire·2026-02-27 12:30

Core Viewpoint - ImmunityBio, Inc. will host a live conference call to provide a business update and review financial results for the year ended December 31, 2025 [1] Group 1: Conference Call Details - The conference call is scheduled for March 3, 2026, at 1:30 p.m. Pacific Time [1] - The call will also cover progress across the company's clinical trial pipeline [1] - The Eastern Time for the call is set for 4:30 p.m. [1]

ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026 - Reportify